Lorbrena 100 mg

Lorbrena 100 mg tablets contain lorlatinib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Pfizer Canada ULC and is designed for specific therapeutic uses.

Lorbrena 100 mg tablets are primarily used in the treatment of advanced non-small cell lung cancer. Lorlatinib, the active ingredient, is a targeted therapy that works by inhibiting specific proteins involved in cancer cell growth. This medication is often prescribed for patients who have certain genetic markers or have not responded to other treatments.

Common effects of Lorbrena 100 mg tablets may include fatigue, nausea, and dizziness. Some individuals might experience changes in mood or appetite. It's important to discuss any persistent or severe effects with a healthcare provider.

Lorbrena 100 mg tablets should be handled with care and stored as directed. This medication may interact with other drugs, so it's crucial to inform your healthcare provider about all medications you are taking. Pregnant women or those planning to become pregnant should consult a healthcare provider before using this medication.

Lorbrena 100 mg tablets may interact with certain medications, including those that are metabolized by the liver. Alcohol and other substances that affect liver function should be avoided. Always consult a healthcare provider before combining Lorbrena with other medications.